|
DCTN4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.78629999999713E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.84309999998289E-06 |
| Normal-vs-Stage2 |
1.754130E-02 |
| Normal-vs-Stage3 |
8.544400E-02 |
| Normal-vs-Stage4 |
1.051360E-01 |
| Stage1-vs-Stage2 |
9.689600E-01 |
| Stage1-vs-Stage3 |
4.771600E-02 |
| Stage1-vs-Stage4 |
1.096580E-01 |
| Stage2-vs-Stage3 |
1.811960E-01 |
| Stage2-vs-Stage4 |
2.529000E-01 |
| Stage3-vs-Stage4 |
9.122200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.56539999995875E-06 |
| Normal-vs-AfricanAmerican |
1.507030E-01 |
| Normal-vs-Asian |
6.697000E-01 |
| Caucasian-vs-AfricanAmerican |
1.06109999997717E-06 |
| Caucasian-vs-Asian |
5.257800E-01 |
| AfricanAmerican-vs-Asian |
2.787200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.63590000000058E-05 |
| Normal-vs-Female |
3.638100E-03 |
| Male-vs-Female |
4.958000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.972800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.236640E-04 |
| Normal-vs-Age(61-80Yrs) |
9.225500E-04 |
| Normal-vs-Age(81-100Yrs) |
1.692390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.746800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.296200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.605200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.178400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.918600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.367000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.215210E-01 |
| Normal-vs-Grade 2 |
1.22550000003496E-06 |
| Normal-vs-Grade 3 |
1.142910E-03 |
| Normal-vs-Grade 4 |
9.999600E-01 |
| Grade 1-vs-Grade 2 |
8.151400E-01 |
| Grade 1-vs-Grade 3 |
7.475400E-01 |
| Grade 1-vs-Grade 4 |
1.466820E-01 |
| Grade 2-vs-Grade 3 |
1.196010E-01 |
| Grade 2-vs-Grade 4 |
1.322750E-03 |
| Grade 3-vs-Grade 4 |
2.130200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.41959810362869E-11 |
| Normal-vs-ccB subtype |
1.504240E-01 |
| ccA subtype-vs-ccB subtype |
1.09219999999688E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.64589999999532E-05 |
| Normal-vs-N1 |
8.926200E-01 |
| N0-vs-N1 |
2.036600E-01 |
|
|
